Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00325533 · ClinicalTrials.gov registry record · NA
Effectiveness of a Barbershop-Based Program to Improve High Blood Pressure Control and Awareness in Black Men
A NA study, sponsored by Cedars-Sinai Medical Center.
- Completed
- Registry status
- NA
- Development phase
- 2,319
- Enrollment target
NCT00325533: Completed NA study, sponsored by Cedars-Sinai Medical Center.
NCT00325533 is a NA study that has completed, run by Cedars-Sinai Medical Center. The registered enrollment target is 2,319 participants, above the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (65% higher). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00325533, a NA study, has completed, sponsored by Cedars-Sinai Medical Center.
- COMPLETED
- Registry status
- NA
- Development phase
- 2,319 participants
- Enrollment target
Study Summary
Black men in the United States have a greater risk of developing high blood pressure than men of any other ethnic or racial group. The purpose of this study is to evaluate the effectiveness of a high blood pressure detection and medical referral program conducted by barbers in predominantly Black barbershops at increasing awareness and lowering blood pressure levels among their Black male customers.
Interventions
- BEHAVIORAL Baseline BP Screening
- OTHER Intensive 10-week Blood Pressure Screening
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 2,319 participants |
| Start Date | 2006-05 |
| Est. Completion | 2009-06 |
| Phase | NA |
What the finished NCT00325533 record still lists
NCT00325533 is an interventional study that assigns participants to a tested intervention. Its 2,319 participants enrollment target places it among the larger protocols in the corpus, above the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (65% higher).
The record links to 0 conditions, and to 2 interventions - of which Baseline BP Screening is the first listed.
NCT00325533 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT00325533 about?
NCT00325533 is a clinical study titled "Effectiveness of a Barbershop-Based Program to Improve High Blood Pressure Control and Awareness in Black Men". Black men in the United States have a greater risk of developing high blood pressure than men of any other ethnic or racial group. The purpose of this study is to evaluate the effectiveness of a high blood pressure detection and medical referral program conducted by barbers in predominantly Black ba...
What is the current status of trial NCT00325533?
This trial is currently completed. It is a NA study. The enrollment target is 2,319 participants. The study started on 2006-05. Estimated completion is 2009-06.
What interventions are being tested in trial NCT00325533?
The interventions under investigation include: Baseline BP Screening (BEHAVIORAL), Intensive 10-week Blood Pressure Screening (OTHER).
Who is sponsoring clinical trial NCT00325533?
This trial is sponsored by Cedars-Sinai Medical Center, which has 339 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT00325533's enrollment target sits among peer trials
2,319 46th of 2000 higher than 1,955 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT05700760 · 2,320 participants · NA
The ROSE Scale-up Study: Informing a Decision About ROSE as Universal PPD Prevention
- NCT06824194 · 2,320 participants · Phase 3
Study of the Safety of a 21-valent Pneumococcal Conjugate Vaccine in Healthy Infants From Approximately 2 Months of Age
- NCT05485961 · 2,310 participants · Phase 2
Combined Dose-Finding and CV Outcomes Study With CSL300 (Clazakizumab) in Adult Subjects With ESKD Undergoing Dialysis
- NCT06679140 · 2,330 participants · Phase 3
A Study to Learn About a Study Medicine Called Ibuzatrelvir in Adult and Adolescent Patients With COVID-19 Who Are Not Hospitalized But Are at Risk For Severe Disease
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia